How Many Cortisone Shots Can You Get in a Lifetime?

There is no established maximum number of cortisone shots you can receive in a lifetime. Guidelines on a hard ceiling simply do not exist, and the commonly repeated limits are more convention than science.¹ What does exist is a widely used rule of thumb, a growing body of evidence about what repeated injections do to joints and the rest of your body, and a set of practical considerations that matter far more than any single number.

Where the “Three or Four Shots” Rule Comes From

If you have asked a doctor how many cortisone injections you can have, you have probably heard some version of “three to four per joint per year.” That guideline has been around for decades and shows up in clinical references going back to the mid-1990s, where reviews recommended limiting injections to roughly four or fewer per joint annually.² The number sounds authoritative, but its origins are surprisingly shaky. A review in the International Journal of Clinical Practice traced the recommendation and concluded that the standard dosing-interval advice appears to have arisen from a misinterpretation of earlier published work, not from trials that tested different schedules head to head.³ That same review recommended that clinicians tailor injection frequency to the individual patient rather than defaulting to a one-size-fits-all cap.

So the rule of thumb is not worthless, but it is less evidence-based than it sounds. Doctors lean on it because it is conservative and because the risks of repeated injection do accumulate. The real question is not “how many am I allowed?” but “what happens to my body with each additional shot, and when do the risks start to outweigh the benefits?”

What Repeated Injections Do to Cartilage

The concern that has gotten the most research attention is cartilage loss. In a two-year randomized trial published in JAMA, patients with knee osteoarthritis received either triamcinolone (a common cortisone formulation) or saline injections every three months. The triamcinolone group lost roughly twice as much cartilage thickness in the affected compartment of the knee as the saline group, and the injections did not produce a meaningful difference in pain.⁴ A commentary in the Annals of Internal Medicine summarized the finding bluntly: intra-articular triamcinolone increased cartilage loss and did not differ from saline for knee pain.⁵

Beyond cartilage thinning, case series have raised alarms about more dramatic structural damage. A radiology expert panel reviewed the evidence and noted that corticosteroid injections have been linked to accelerated osteoarthritis progression, stress fractures beneath the joint surface, worsening of pre-existing bone death, and rapid joint destruction including bone loss.⁶ These outcomes are not common, but they tend to show up in patients who have received multiple injections over time, and they are essentially irreversible.

The picture is not entirely one-sided, though. An older review of joint injection outcomes in different patient populations found no joint space loss in osteoarthritic knees that received multiple injections, and no worsening erosions in rheumatoid arthritis knees after a single injection.⁷ The conflicting data may reflect differences in how many injections were given, which corticosteroid was used, and how damaged the joint already was. For most clinicians, the JAMA trial tipped the balance toward caution, especially for patients considering open-ended repeat injections.

Tendon Risks From Nearby Injections

Cortisone is not always injected directly into a joint. Shots around tendons, into bursae, or near other soft tissue structures carry a different risk profile. The big worry with tendons is rupture. Corticosteroids can inhibit the production of collagen that holds tendons together and impair local blood supply, setting off a degenerative process that can progress from partial tearing to a complete snap.⁸ The Achilles tendon is the most well-known example, but the hands are vulnerable too. A retrospective study of hand tendinitis patients documented spontaneous tendon rupture as a rare but serious complication of corticosteroid injection.⁹

This is one area where the injection site really matters. A cortisone shot into a large knee joint is a very different proposition than one delivered right next to a weight-bearing tendon. Many practitioners limit tendon-area injections to one or two lifetime doses for a specific site, and some avoid them altogether for tendons under high mechanical load.

Systemic Effects You Might Not Expect

Even though the shot goes into a specific spot, the steroid does not stay there. Cortisone is absorbed into the bloodstream, and in some people the amount that reaches the rest of the body is enough to cause systemic side effects. These can include facial flushing, short-term blood pressure increases, temporary blood sugar spikes, and in some cases suppression of the body’s own cortisol production.¹

The cortisol-production issue, known as adrenal suppression, is worth understanding because it can linger. Your adrenal glands normally produce cortisol on demand, but when an outside source of steroid floods the system, the glands can temporarily shut down. Case reports have documented this happening even after a single joint injection.¹⁰ A case report in Endocrine Practice confirmed the same pattern: systemic absorption of injected corticosteroids can suppress the hormonal axis that controls your natural cortisol.¹¹ In most people the effect resolves on its own, but in someone getting multiple injections across different joints in a short period, the cumulative systemic dose can become meaningful.

Blood Sugar Spikes in People With Diabetes

If you have diabetes, cortisone shots require extra caution. Research consistently shows that blood glucose rises sharply on the first day after injection and often stays elevated on day two before returning to baseline. A study of diabetic patients receiving musculoskeletal steroid injections found a significant glucose increase on the first day after the shot, with patients whose diabetes was poorly controlled before the injection experiencing the biggest spikes.¹² A separate study focused on hand and wrist injections found statistically significant increases in fasting blood glucose on days one and two, with type 1 diabetes and insulin use both predicting larger spikes.¹³

Interestingly, the size of the joint and the amount of steroid injected may influence how much glucose rises. A study comparing injection sites found that knee injections produced significant fasting glucose elevations on days one and two, whereas shoulder, wrist, and hand injections did not cause significant spikes. Pre-injection hemoglobin A1C was the strongest predictor of how high glucose would climb, while the actual steroid dose and number of injections did not have a significant effect on the elevation. No cases of diabetic ketoacidosis occurred in any of the patients studied.¹⁴ The practical upshot: if you have diabetes and are scheduled for a cortisone injection, monitoring your blood sugar closely for the first day or two is important, and your doctor may want to adjust your diabetes medications temporarily.

Do Cortisone Shots Weaken Your Bones?

Systemic oral steroids taken for weeks or months are a well-known cause of bone loss. People sometimes worry that injected cortisone carries the same risk. The evidence here is surprisingly reassuring for most people. A large study published in JAMA Network Open examined whether cumulative cortisone injection doses were associated with fracture risk and found no significant association. The adjusted analysis showed that higher cumulative injection doses did not increase fracture risk overall, and the same held true for patients with osteoporosis or other high-risk profiles. The only factors that predicted fractures were age, other medical conditions, and having fractured before.¹⁵

There is a caveat, though. A study of postmenopausal women with low back pain who had received frequent epidural steroid injections, averaging around 14 injections with a cumulative triamcinolone dose of about 400 mg, showed lower bone mineral density in the hip compared to women who had fewer injections.¹⁶ Epidural injections deliver steroid into a space with rich blood supply, which may increase systemic absorption. So the answer depends on context: for standard joint injections at typical frequencies, bone density does not appear to be a major concern. For people receiving many epidural injections over years, especially postmenopausal women, monitoring bone health is reasonable.

Timing Injections Before Joint Replacement Surgery

One of the most clinically important considerations around cortisone shots has nothing to do with lifetime totals and everything to do with timing. If your joint is deteriorating to the point where surgery becomes likely, when you last had a cortisone injection matters a great deal. A study of over 76,000 total knee replacements found that a corticosteroid injection within two weeks before surgery nearly tripled the odds of postoperative infection.¹⁷ Injections given more than a month before surgery did not show a significant increase in infection risk in that particular analysis.

For hip replacements, the window of concern may be longer. A meta-analysis found that corticosteroid injections within three months before total hip replacement significantly increased the risk of joint infection after surgery.¹⁸ A separate systematic review focused on knee replacements also found elevated infection risk when injections were given less than three months before surgery.¹⁹ The practical message: if you and your surgeon are starting to talk about joint replacement, make sure the conversation includes how recently you had your last cortisone shot. Many surgeons now want a minimum three-month gap between the last injection and the operating date.

Infection Risk From the Injection Itself

Septic arthritis, a joint infection caused by bacteria entering during or shortly after an injection, is rare but serious. A retrospective analysis found that when it did occur, the median time to diagnosis was about three and a half weeks after the injection, though infections showed up anywhere from one to sixteen weeks later. The knee was the most commonly affected joint, and Staphylococcus aureus was the bacterium most often responsible.²⁰ This risk exists with every injection, so while any single shot carries a very low probability of infection, the cumulative exposure from many injections over a lifetime incrementally raises your chances of encountering it at least once.

Why the Joint Being Treated Matters

Not every joint responds to cortisone the same way, and the duration of relief varies substantially by condition and anatomy. In children with juvenile idiopathic arthritis, a single knee injection can produce remission lasting well over six months, with an average duration of about 1.2 years. In adults with osteoarthritis of the knee, the same type of injection provides pain relief for roughly three weeks. Rheumatoid arthritis knees fall in between at about eight weeks.⁷ Osteoarthritis of the knee is the most common reason people get repeated cortisone shots, and it is also the condition where each shot provides the shortest relief window, which naturally pushes patients toward asking for more injections more often.

Cortisone shots are also widely used for shoulder bursitis, plantar fasciitis, hip arthritis, and trigger finger. The risk-benefit calculation shifts for each location. A small joint in the hand involves less steroid, less systemic absorption, and a different set of local risks compared to a large weight-bearing joint like the knee or hip. When your doctor counts up how many shots you have had, the count per specific joint matters more than the total across your whole body.

Extended-Release Formulations

Part of the reason standard cortisone shots wear off quickly is that the steroid disperses from the joint into the bloodstream within hours. An extended-release formulation of triamcinolone acetonide, packaged inside tiny biodegradable microspheres, was designed to address exactly this problem. The microspheres slowly dissolve inside the joint, releasing the drug over weeks instead of all at once. This keeps the steroid in the joint longer and dramatically reduces the amount that reaches the rest of the body.²¹

A pharmacokinetic study comparing the extended-release version to a standard crystalline suspension illustrated the difference starkly. After the standard injection, blood levels of the steroid peaked at about 9,600 pg/mL within four hours. After the extended-release version, the peak was only about 836 pg/mL, reached slowly over 24 hours, and levels declined gradually over 12 to 20 weeks.²² Lower systemic exposure means fewer blood sugar spikes, less adrenal suppression, and potentially fewer bone density concerns. Whether the extended-release version also causes less cartilage damage over time is still an open question, but the pharmacokinetic profile is encouraging.

Alternatives That May Reduce Your Need for Cortisone

For people who are approaching whatever informal injection limit their doctor has set, or who simply want to reduce how much steroid goes into their joints, other injectables have entered the picture. Platelet-rich plasma, or PRP, is the most studied. In a prospective randomized trial of patients with moderate knee osteoarthritis, a single PRP injection reduced pain just as fast as cortisone at one week. By the one-year mark, the PRP group had a substantially larger reduction in pain scores: about a 52% improvement from baseline compared to roughly 14% in the cortisone group.²³ Other trials comparing PRP to cortisone have found similar patterns: equivalent short-term relief but better outcomes for PRP at six months and beyond.²⁴

PRP is not a perfect substitute. It typically costs more out of pocket because insurance coverage is inconsistent, it requires a blood draw and processing before injection, and its quality varies depending on how the sample is prepared. A trial comparing PRP plasma gel, hyaluronic acid, cortisone, and combinations of all three found that the combination of PRP gel, hyaluronic acid, and cortisone together produced the most consistent improvement at six months, though the differences between groups were not statistically significant after adjustment.²⁵ The research is still maturing, but for patients who want to space out or minimize cortisone use, PRP is the most credible option currently available.

How Doctors Actually Decide When to Stop

In practice, the decision to keep giving or stop giving cortisone shots is rarely about hitting a magic number. Doctors consider how much relief each injection provides and how long it lasts. If a shot that used to help for two months now helps for two weeks, the trajectory is headed in the wrong direction. They consider what the imaging shows: if MRI or X-rays reveal accelerating joint damage, continuing to inject the joint may be masking a problem that needs a different solution. They also weigh what else is going on in your body. Someone with well-controlled health and a single problematic joint is in a very different position than someone with diabetes, osteoporosis, and injections happening in multiple joints simultaneously.

The absence of a firm lifetime limit is not an oversight. It reflects the reality that the harms of cortisone accumulate differently in every person. Osteoarthritis itself is not simply wear and tear but an active disease process involving inflammation throughout the joint, including the cartilage, the lining, the bone underneath, and the surrounding ligaments.²⁶ Cortisone calms that inflammation temporarily, and for many people the short-term benefit is real and valuable. The question is always whether the next injection is still buying you meaningful time and comfort, or whether it is just adding risk to a joint that has already told you it needs something more definitive.

Skin Changes and Cosmetic Effects

One side effect that catches people off guard is skin changes near the injection site. Cortisone can cause local fat atrophy, leaving a visible dent or thinning of the skin, and in people with darker skin tones, lightening of the skin around the injection site is a recognized complication.²⁷ These cosmetic effects are generally not dangerous, but they can be permanent. They are more likely with injections given closer to the skin surface, such as shots for trigger finger or tennis elbow, than with deep joint injections. If you have already noticed a dent or a pale spot from a previous shot, it is worth mentioning to your doctor before the next one, because repeated injection into the same superficial site increases the likelihood that the cosmetic damage will become more noticeable.